Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST
Jazz Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,036 | 1,392 | 2,413 | 1,506 | 881.48 | 591.45 |
Short-Term Investments | 820 | 1,050 | 580 | 120 | - | - |
Trading Asset Securities | - | - | 0.96 | 3.78 | - | - |
Cash & Short-Term Investments | 2,856 | 2,442 | 2,994 | 1,630 | 881.48 | 591.45 |
Cash Growth | 39.60% | -18.44% | 83.66% | 84.93% | 49.04% | -72.27% |
Receivables | 873.7 | 830.75 | 716.77 | 705.79 | 651.49 | 563.36 |
Inventory | 454 | 416.96 | 480.45 | 597.04 | 714.06 | 1,073 |
Prepaid Expenses | 170.9 | 152.48 | 177.41 | 185.48 | 91.91 | 131.41 |
Other Current Assets | 258.4 | 323.95 | 260.58 | 317.03 | 267.19 | 252.39 |
Total Current Assets | 4,613 | 4,166 | 4,629 | 3,435 | 2,606 | 2,611 |
Property, Plant & Equipment | 292 | 258.74 | 227 | 234.99 | 301.38 | 343.42 |
Long-Term Investments | 15.6 | 4.3 | 4.33 | 4.7 | 5.5 | 5 |
Goodwill | 1,803 | 1,829 | 1,716 | 1,753 | 1,693 | 1,828 |
Other Intangible Assets | 4,174 | 4,430 | 4,756 | 5,418 | 5,794 | 7,152 |
Long-Term Deferred Tax Assets | 998.7 | 869.13 | 560.25 | 477.83 | 376.25 | 311.1 |
Long-Term Deferred Charges | 6.1 | 7.55 | 9.49 | 6.48 | 9.25 | 12.03 |
Other Long-Term Assets | 95.4 | 94.73 | 110.15 | 62.76 | 49.64 | 35.81 |
Total Assets | 11,998 | 11,659 | 12,012 | 11,393 | 10,835 | 12,299 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 380.3 | 122.06 | 77.87 | 102.75 | 90.76 | 100.3 |
Accrued Expenses | 1,011 | 974.51 | 821.98 | 748.21 | 757.86 | 588.41 |
Current Portion of Long-Term Debt | 1,017 | 1,030 | 31 | 604.95 | 31 | 46.23 |
Current Portion of Leases | 14.9 | 14.72 | 14.78 | 19.45 | 15.94 | 15.76 |
Current Income Taxes Payable | 59.2 | 56.39 | 18.76 | 35.07 | 7.72 | 9.61 |
Current Unearned Revenue | - | - | - | - | 0.46 | 2.09 |
Other Current Liabilities | 50.2 | 44.95 | 74.19 | 26.26 | 29.46 | 46.9 |
Total Current Liabilities | 2,533 | 2,243 | 1,039 | 1,537 | 933.19 | 809.3 |
Long-Term Debt | 4,552 | 4,328 | 6,078 | 5,111 | 5,693 | 6,019 |
Long-Term Leases | 60.7 | 54.33 | 43.5 | 64.26 | 77.05 | 93.47 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.46 |
Long-Term Deferred Tax Liabilities | 506.1 | 594.47 | 676.74 | 847.71 | 944.34 | 1,301 |
Other Long-Term Liabilities | 153.8 | 121.08 | 82.05 | 96.3 | 101.6 | 110.73 |
Total Liabilities | 7,806 | 7,341 | 7,919 | 7,656 | 7,750 | 8,333 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 4,414 | 4,240 | 3,914 | 3,700 | 3,477 | 3,535 |
Retained Earnings | 423.6 | 646.18 | 1,127 | 878.66 | 733.59 | 830.23 |
Comprehensive Income & Other | -646 | -568.07 | -947.14 | -841.62 | -1,125 | -399.83 |
Shareholders' Equity | 4,192 | 4,319 | 4,094 | 3,737 | 3,086 | 3,965 |
Total Liabilities & Equity | 11,998 | 11,659 | 12,012 | 11,393 | 10,835 | 12,299 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,645 | 5,427 | 6,167 | 5,800 | 5,817 | 6,174 |
Net Cash (Debt) | -2,789 | -2,985 | -3,173 | -4,170 | -4,936 | -5,583 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -41.82 | -48.96 | -48.07 | -57.86 | -78.92 | -93.53 |
Filing Date Shares Outstanding | 64.19 | 61.56 | 60.73 | 62.35 | 63.33 | 61.74 |
Total Common Shares Outstanding | 64.1 | 61.44 | 60.63 | 62.26 | 63.21 | 61.63 |
Working Capital | 2,080 | 1,924 | 3,590 | 1,899 | 1,673 | 1,802 |
Book Value Per Share | 65.39 | 70.30 | 67.52 | 60.03 | 48.82 | 64.34 |
Tangible Book Value | -1,785 | -1,940 | -2,378 | -3,434 | -4,401 | -5,015 |
Tangible Book Value Per Share | -27.84 | -31.58 | -39.22 | -55.16 | -69.63 | -81.36 |
Land | 71.9 | 72.23 | 71.9 | 70.91 | 68.94 | 64.01 |
Machinery | 131.6 | 129.33 | 116.14 | 107.57 | 100.49 | 99.73 |
Construction In Progress | 83.1 | 49.64 | 34.49 | 18.66 | 67.39 | 86.51 |
Leasehold Improvements | 68 | 63.57 | 70.2 | 67.72 | 64.78 | 66.32 |